SCHEMBL12818110

SCHEMBL12818110

Cc1noc(C)c1-c1ccc2c(c1)N(S(=O)(=O)c1ccc3c(ccn3C)c1)CCO2

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 2/20 0.45
▸ BRD4 O60885 8/20 0.42
▸ BRD2 P25440 6/20 0.42
▸ BRD3 Q15059 6/20 0.42
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ KDM2B Q8NHM5 1/20 0.41
▸ CYP2C9 P11712 1/20 0.40
▸ DRD2 P14416 1/20 0.39
▸ HTR2A P28223 1/20 0.39
▸ HTR2C P28335 1/20 0.39
▸ DRD3 P35462 1/20 0.39
▸ HTR6 P50406 1/20 0.39
▸ PKM P14618 1/20 0.39
▸ PKLR P30613 1/20 0.39
▸ PDE3B Q13370 1/20 0.38
▸ PDE3A Q14432 1/20 0.38
▸ TP53 P04637 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12819074 0.85 CYP2C9 (0.51) MAPTMEN1KMT2AKDM2BCYP2C9
SCHEMBL12818629 0.83 HTR6 (0.41) MAPTMEN1KMT2AKDM2BCYP2C9
SCHEMBL12817919 0.83 BRD4 (0.41) BRD4BRD2BRD3KDM2BDRD2
SCHEMBL12818722 0.83 KDM2B (0.41) MAPTMEN1KMT2AKDM2BCYP2C9
SCHEMBL12818382 0.81 MAPT (0.44) MAPTBRD4BRD2BRD3MEN1
SCHEMBL12817704 0.81 KDM2B (0.40) MAPTMEN1KMT2AKDM2BCYP2C9
SCHEMBL12818708 0.81 BRD4 (0.45) MAPTBRD4BRD2BRD3MEN1
SCHEMBL12819192 0.80 MEN1 (0.40) MAPTMEN1KMT2AKDM2BCYP2C9
SCHEMBL12818102 0.80 BRD4 (0.45) MAPTBRD4BRD2BRD3MEN1
SCHEMBL12818264 0.79 PDE3B (0.39) MAPTMEN1KMT2AKDM2BCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012130306-A1 BICYCLIC 2,3-DIHYRDOBENZAZINE COMPOUNDS FOR USE IN THERAPY ELARA PHARMACEUTICALS GMBH (DE) 2012-10-04 — — WO disclosed
Send feedback